Iradimed (IRMD) Competitors $53.11 -0.73 (-1.36%) (As of 12:45 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends IRMD vs. IRTC, CNMD, WRBY, SLNO, TNDM, RXST, INMD, MDXG, ESTA, and PLSEShould you be buying Iradimed stock or one of its competitors? The main competitors of Iradimed include iRhythm Technologies (IRTC), CONMED (CNMD), Warby Parker (WRBY), Soleno Therapeutics (SLNO), Tandem Diabetes Care (TNDM), RxSight (RXST), InMode (INMD), MiMedx Group (MDXG), Establishment Labs (ESTA), and Pulse Biosciences (PLSE). These companies are all part of the "medical equipment" industry. Iradimed vs. iRhythm Technologies CONMED Warby Parker Soleno Therapeutics Tandem Diabetes Care RxSight InMode MiMedx Group Establishment Labs Pulse Biosciences Iradimed (NASDAQ:IRMD) and iRhythm Technologies (NASDAQ:IRTC) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, valuation, risk, institutional ownership, analyst recommendations, media sentiment, community ranking, earnings and profitability. Does the MarketBeat Community prefer IRMD or IRTC? iRhythm Technologies received 151 more outperform votes than Iradimed when rated by MarketBeat users. Likewise, 66.17% of users gave iRhythm Technologies an outperform vote while only 64.78% of users gave Iradimed an outperform vote. CompanyUnderperformOutperformIradimedOutperform Votes25264.78% Underperform Votes13735.22% iRhythm TechnologiesOutperform Votes40366.17% Underperform Votes20633.83% Does the media prefer IRMD or IRTC? In the previous week, iRhythm Technologies had 5 more articles in the media than Iradimed. MarketBeat recorded 11 mentions for iRhythm Technologies and 6 mentions for Iradimed. iRhythm Technologies' average media sentiment score of 1.58 beat Iradimed's score of 0.56 indicating that iRhythm Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Iradimed 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive iRhythm Technologies 8 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has higher valuation & earnings, IRMD or IRTC? Iradimed has higher earnings, but lower revenue than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Iradimed, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIradimed$65.56M10.40$17.19M$1.4636.87iRhythm Technologies$492.68M5.58-$123.41M-$4.86-18.09 Do analysts prefer IRMD or IRTC? Iradimed presently has a consensus price target of $60.00, indicating a potential upside of 11.45%. iRhythm Technologies has a consensus price target of $108.50, indicating a potential upside of 23.44%. Given iRhythm Technologies' higher probable upside, analysts plainly believe iRhythm Technologies is more favorable than Iradimed.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Iradimed 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00iRhythm Technologies 0 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.90 Do insiders & institutionals believe in IRMD or IRTC? 92.3% of Iradimed shares are owned by institutional investors. 37.1% of Iradimed shares are owned by company insiders. Comparatively, 0.7% of iRhythm Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has more risk & volatility, IRMD or IRTC? Iradimed has a beta of 0.79, indicating that its stock price is 21% less volatile than the S&P 500. Comparatively, iRhythm Technologies has a beta of 1.23, indicating that its stock price is 23% more volatile than the S&P 500. Is IRMD or IRTC more profitable? Iradimed has a net margin of 26.12% compared to iRhythm Technologies' net margin of -26.90%. Iradimed's return on equity of 23.99% beat iRhythm Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Iradimed26.12% 23.99% 20.45% iRhythm Technologies -26.90%-120.86%-17.96% SummaryIradimed beats iRhythm Technologies on 10 of the 18 factors compared between the two stocks. Ad Porter & CompanyUrgent: This election is riggedIf you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. Get Iradimed News Delivered to You Automatically Sign up to receive the latest news and ratings for IRMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IRMD vs. The Competition Export to ExcelMetricIradimedSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$682.09M$4.45B$5.36B$8.94BDividend Yield1.11%43.03%5.33%4.05%P/E Ratio36.8725.91117.6718.00Price / Sales10.4052.031,424.20155.72Price / Cash37.8755.4242.8038.60Price / Book8.186.307.356.66Net Income$17.19M$13.60M$118.46M$224.93M7 Day Performance2.06%2.64%3.40%2.50%1 Month Performance11.46%7.38%2.49%10.24%1 Year Performance26.88%46.32%36.17%30.14% Iradimed Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IRMDIradimed4.7939 of 5 stars$53.11-1.4%$60.00+13.0%+26.9%$672.90M$65.56M36.38110Insider TradeShort Interest ↑IRTCiRhythm Technologies3.7099 of 5 stars$85.82-1.3%$108.50+26.4%-1.5%$2.69B$492.68M-17.892,000Analyst ForecastShort Interest ↓Positive NewsGap DownCNMDCONMED4.1784 of 5 stars$75.47+1.9%$79.80+5.7%-30.7%$2.33B$1.29B17.714,000Positive NewsWRBYWarby Parker2.704 of 5 stars$22.11-1.9%$18.82-14.9%+99.3%$2.25B$669.77M-83.483,491Positive NewsSLNOSoleno Therapeutics4.8467 of 5 stars$50.94-3.4%$74.83+46.9%+67.6%$2.20BN/A-15.8830Analyst ForecastNews CoverageTNDMTandem Diabetes Care4.7574 of 5 stars$32.29+5.4%$54.25+68.0%+53.4%$2.12B$747.72M-17.252,400Analyst UpgradePositive NewsRXSTRxSight2.7729 of 5 stars$45.85-2.2%$61.63+34.4%+55.6%$1.85B$128.29M-55.28220INMDInMode2.3534 of 5 stars$19.54+0.1%$22.60+15.7%-20.8%$1.64B$492.05M10.52480News CoveragePositive NewsMDXGMiMedx Group3.659 of 5 stars$9.34+1.0%$12.00+28.5%+17.4%$1.37B$342.80M16.82895Positive NewsESTAEstablishment Labs2.5228 of 5 stars$47.00+2.4%$60.60+28.9%+78.8%$1.32B$153.07M-17.79960Positive NewsPLSEPulse Biosciences1.736 of 5 stars$20.81-2.8%N/A+127.9%$1.28B$700,000.000.00140Short Interest ↓ Related Companies and Tools Related Companies IRTC Competitors CNMD Competitors WRBY Competitors SLNO Competitors TNDM Competitors RXST Competitors INMD Competitors MDXG Competitors ESTA Competitors PLSE Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:IRMD) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredEven Trump can’t stop what’s coming.No matter who sits in the White House over the next four years, a series of events has been triggered that cou...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Iradimed Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Iradimed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
